Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Leap Therapeutics, Inc.
University of Nebraska
Augusta University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bostwick Laboratories